Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 189

1.

Organic infrared upconversion device.

Kim DY, Song DW, Chopra N, De Somer P, So F.

Adv Mater. 2010 May 25;22(20):2260-3. doi: 10.1002/adma.200903312. No abstract available.

PMID:
20352630
2.

Prophylaxis in cardiac surgery. A controlled randomized comparison between cefazolin and cefuroxime.

Wellens F, Pirlet M, Larbuisson R, De Meireleire F, De Somer P.

Eur J Cardiothorac Surg. 1995;9(6):325-9.

PMID:
7546806
3.

The inhibition of endotoxin-induced local inflammation by LDH virus or LDH virus-infected tumors is mediated by interferon.

Heremans H, Billiau A, Coutelier JP, De Somer P.

Proc Soc Exp Biol Med. 1987 May;185(1):6-15.

PMID:
3033682
4.

Cloning of cDNA coding for human tissue-type plasminogen activator and its expression in Escherichia coli.

Harris TJ, Patel T, Marston FA, Little S, Emtage JS, Opdenakker G, Volckaert G, Rombauts W, Billiau A, De Somer P.

Mol Biol Med. 1986 Jun;3(3):279-92.

PMID:
3090401
5.

Influence of carbohydrate side chains on activity of tissue-type plasminogen activator.

Opdenakker G, Van Damme J, Bosman F, Billiau A, De Somer P.

Proc Soc Exp Biol Med. 1986 Jun;182(2):248-57.

PMID:
3085108
6.

Determination of tissue-type plasminogen-activator mRNA in human and non-human cell lines by dot-blot hybridization.

Opdenakker G, Billiau A, Volckaert G, de Somer P.

Biochem J. 1985 Oct 15;231(2):309-13.

7.

Stimulation of fibroblast interferon production by a 22K protein from human leukocytes.

Van Damme J, Opdenakker G, Billiau A, De Somer P, De Wit L, Poupart P, Content J.

J Gen Virol. 1985 Apr;66 ( Pt 4):693-700.

PMID:
3981135
8.

Homogeneous interferon-inducing 22K factor is related to endogenous pyrogen and interleukin-1.

Van Damme J, De Ley M, Opdenakker G, Billiau A, De Somer P, Van Beeumen J.

Nature. 1985 Mar 21-27;314(6008):266-8.

PMID:
3920526
9.

Molecular cloning of murine interferon gamma (MuIFN-gamma) cDNA and its expression in heterologous mammalian cells.

Dijkmans R, Volckaert G, Van Damme J, De Ley M, Billiau A, De Somer P.

J Interferon Res. 1985 Summer;5(3):511-20.

PMID:
2997340
10.

An interferon-beta-like or interferon-inducing protein released by mitogen-stimulated human leukocytes.

Van Damme J, Billiau A, De Ley M, De Somer P.

J Gen Virol. 1983 Aug;64 (Pt 8):1819-22.

PMID:
6875520
11.

Effects of 12-O-tetradecanoylphorbol 13-acetate on the production of mRNAs for human tissue-type plasminogen activator.

Opdenakker G, Ashino-Fuse H, Van Damme J, Billiau A, De Somer P.

Eur J Biochem. 1983 Apr 5;131(3):481-7.

12.

Interferon induced in mouse spleen cells by Staphylococcus aureus.

Heremans H, De Ley M, Billiau A, De Somer P.

Cell Immunol. 1982 Aug;71(2):353-64. No abstract available.

PMID:
6183012
13.

Messenger RNA for human tissue plasminogen activator.

Opdenakker G, Weening H, Collen D, Billiau A, de Somer P.

Eur J Biochem. 1982 Jan;121(2):269-74.

14.

Specific lysis of an iliofemoral thrombus by administration of extrinsic (tissue-type) plasminogen activator.

Weimar W, Stibbe J, van Seyen AJ, Billiau A, De Somer P, Collen D.

Lancet. 1981 Nov 7;2(8254):1018-20. No abstract available.

PMID:
6118479
15.

Interferon induced in human leukocytes by concanavalin A: isolation and characterization of gamma- and beta-type components.

Van Damme J, De Ley M, Claeys H, Billiau A, Vermylen C, De Somer P.

Eur J Immunol. 1981 Nov;11(11):937-42.

PMID:
6173233
16.

The preparation of antibodies directed against human immune interferon.

De Ley M, Van Damme J, Billiau A, De Somer P.

J Virol Methods. 1981 Oct;3(3):149-53.

PMID:
6170651
17.

Interferon therapy in multiple myeloma: failure of human fibroblast interferon administration to the course of light chain disease.

Billiau A, Bloemmen J, Bogaerts M, Claeys H, Van Damme J, De Ley M, de Somer P, Drochmans A, Heremans H, Kriel A, Schetz J, Tricot G, Vermylen C, Verwilghen R, Waer M.

Eur J Cancer Clin Oncol. 1981 Aug;17(8):875-82. No abstract available.

PMID:
6173221
18.

Inhibitory effect of a broad-spectrum antiviral agent, (S)-9-(2,3-dihydroxypropyl)adenine, on spermatogenesis in mice.

De Clercq E, Leyten R, Sobis H, Matousek J, Holý A, De Somer P.

Toxicol Appl Pharmacol. 1981 Jul;59(3):441-51. No abstract available.

PMID:
7268768
19.

Purification of human fibroblast interferon by zinc chelate chromatography.

Heine JW, Van Damme J, de Ley M, Billiau A, de Somer P.

J Gen Virol. 1981 May;54(Pt 1):47-56.

PMID:
6169789
20.

Characteristics of HuIFN-gamma and HuIFN-beta induced by mitogenic stimulation of human leukocytes.

Billiau A, Van Damme J, De Ley M, De Somer P.

Tex Rep Biol Med. 1981-1982;41:184-91. No abstract available.

PMID:
6817437
21.

Tissue distribution of human interferons after exogenous administration in rabbits, monkeys, and mice.

Billiau A, Heremans H, Ververken D, van Damme J, Carton H, de Somer P.

Arch Virol. 1981;68(1):19-25.

PMID:
6166278
22.

The clinical value of interferon--a critical appraisal.

Billiau A, de Somer P, Schellekens H, Weimar W.

Neth J Med. 1981;24(2):72-8. Review. No abstract available.

PMID:
6165902
23.

Tumorigenicity and interferon properties of the PLC/PRF/5 human hepatoma cell line.

Desmyter J, De Groote G, Ray MB, Bradburne AF, Desmet V, De Somer P, Alexander J.

Prog Med Virol. 1981;27:103-8. No abstract available.

PMID:
6165050
24.

Oral (E)-5-(2-bromovinyl)-2'-deoxyuridine in severe herpes zoster.

de Clercq E, Degreef H, Wildiers J, de Jonge G, Drochmans A, Descamps J, de Somer P.

Br Med J. 1980 Nov 1;281(6249):1178. No abstract available.

25.

Interferon induced in human leukocytes by mitogens: production, partial purification and characterization.

de Ley M, van Damme J, Claeys H, Weening H, Heine JW, Billiau A, Vermylen C, de Somer P.

Eur J Immunol. 1980 Nov;10(11):877-83.

PMID:
6161829
27.

Neutralization of interferon activity in homologous and heterologous cells with homologous and heterologous antibody.

Braude IA, De Clercq E, Zhen-Xi Z, Edy VG, De Somer P.

Proc Soc Exp Biol Med. 1980 Oct;165(1):161-6. No abstract available.

PMID:
6158740
28.

Alopecia in laboratory animals induced by a polyampholyte, polyethylene alanine.

De Clercq E, Descamps J, De Somer P, Samyn C, Smets G.

Experientia. 1980 Sep 15;36(9):1107-8.

PMID:
7418853
29.

(E)-5-(2-bromovinyl)-2'-Deoxyuridine in the treatment of experimental herpes simplex keratitis.

Maudgal PC, De Clercq E, Descamps J, Missotten L, De Somer P, Busson R, Vanderhaeghe H, Verhelst G, Walker RT, Jones AS.

Antimicrob Agents Chemother. 1980 Jan;17(1):8-12.

30.

Tolerability of pure fibroblast interferon in man.

Billiau A, Heine JW, Van Damme J, Heremans H, De Somer P.

Ann N Y Acad Sci. 1980;350:374-5. No abstract available.

PMID:
6165288
31.

Treatment of Crohn's disease with interferon. A preliminary clinical trial.

Vantrappen G, Coremans G, Billiau A, De Somer P.

Acta Clin Belg. 1980;35(4):238-42. No abstract available.

PMID:
6165182
32.

Pharmacokinetics of E-5-(2-bromovinyl)-2'-deoxyuridine in mice.

de Clercq E, Descamps J, de Somer P, Barr PJ, Jones AS, Walker RT.

Antimicrob Agents Chemother. 1979 Aug;16(2):234-6.

33.

Interferon-induced synthesis of a 63,000 dalton protein in mouse cells.

De Ley M, Billiau A, De Somer P.

Biochem Biophys Res Commun. 1979 Jul 27;89(2):701-5. No abstract available.

PMID:
486190
34.

Human fibroblast interferon for clinical trials: production, partial purification, and characterization.

Billiau A, Damme JV, Leuven FV, Edy VG, De Ley M, Cassiman JJ, Van de Berghe H, De Somer P.

Antimicrob Agents Chemother. 1979 Jul;16(1):49-55.

35.

(E)-5-(2-Bromovinyl)-2'-deoxyuridine: a potent and selective anti-herpes agent.

De Clercq E, Descamps J, De Somer P, Barr PJ, Jones AS, Walker RT.

Proc Natl Acad Sci U S A. 1979 Jun;76(6):2947-51.

36.

Interferon treatment of NZB mice: accelerated progression of autoimmune disease.

Heremans H, Billiau A, Colombatti A, Hilgers J, de Somer P.

Infect Immun. 1978 Sep;21(3):925-30.

37.

A semi-continuous system for the production of human interferon in lymphoblastoid cell cultures.

De Ley M, Billiau A, De Somer P.

J Gen Virol. 1978 Aug;40(2):455-8.

PMID:
690609
38.

Double-blind study of interferon administration in renal transplant recipients.

Weimar W, Schellekens H, Lameijer LD, Masurel N, Edy VG, Billiau A, De Somer P.

Eur J Clin Invest. 1978 Aug;8(4):255-8.

PMID:
100331
39.

(S)-9-(2,3-Dihydroxypropyl)adenine: An Aliphatic Nucleoside Analog with Broad-Spectrum Antiviral Activity.

DE Clercq E, Descamps J, DE Somer P, Holyacute A.

Science. 1978 May 5;200(4341):563-5.

PMID:
17839440
40.

(S)-9-(2,3-Dihydroxypropyl)adenine: an aliphatic nucleoside analog with broad-spectrum antiviral activity.

De Clercq E, Descamps J, De Somer P, Holý A.

Science. 1978 May 5;200(4341):UNKNOWN.

PMID:
205946
41.

Non-appearance of injected fibroblast interferon in circulation.

Edy VG, Billiau A, De Somer P.

Lancet. 1978 Feb 25;1(8061):451-2. No abstract available.

PMID:
75485
42.

In vitro cultivation of human tumor tissues. II. Morphological and virological characterization of three cell lines.

Heremans H, Billiau A, Cassiman JJ, Mulier JC, de Somer P.

Oncology. 1978;35(6):246-52.

PMID:
218153
43.

Interferon inhibits C-type virus at a posttranscriptional, prerelease step.

Billiau A, Heremans H, Allens PT, Baron S, de Somer P.

Arch Virol. 1978;57(3):205-20.

PMID:
79409
44.

Fibroblast interferon in HBsAg-positive chronic active hepatitis.

Weimar W, Heijtink RA, Schalm SW, van Blankenstein M, Schellekens H, Masurel N, Edy VG, Billiau A, De Somer P.

Lancet. 1977 Dec 17;2(8051):1282. No abstract available.

PMID:
73970
45.

Identification of the human plasma protein which inhibits fibrinolysis associated with malignant cells.

Collen D, Billiau A, Edy J, De Somer P.

Biochim Biophys Acta. 1977 Sep 29;499(2):194-201. No abstract available.

PMID:
198009
46.

Purification of human fibroblast interferon by zinc chelate affinity chromatography.

Edy VG, Billiau A, de Somer P.

J Biol Chem. 1977 Sep 10;252(17):5934-5.

47.

Interferon-induced skin reactivity in man.

De Somer P, Edy VG, Billiau A.

Lancet. 1977 Jul 2;2(8027):47-8. No abstract available.

PMID:
69141
48.

Human interferon: mass production in a newly established cell line, MG-63.

Billiau A, Edy VG, Heremans H, Van Damme J, Desmyter J, Georgiades JA, De Somer P.

Antimicrob Agents Chemother. 1977 Jul;12(1):11-5.

49.

Stable and unstable forms of human fibroblast interferon.

Edy VG, Desmyter J, Billiau A, De Somer P.

Infect Immun. 1977 May;16(2):445-8.

50.

Analysis of murine C-type virus structural proteins by rocket and crossed immunoelectrophoresis.

Georgiades JA, Billiau A, Verbruggen R, de Somer P.

J Immunol Methods. 1977;17(1-2):177-87.

PMID:
198476

Supplemental Content

Loading ...
Support Center